Market Snapshot
S&P Futures
3,809.5
Dow Futures
30,868
Nasdaq Futures
11,633.25
Aeglea BioTherapeutics, Inc.
(NASDAQ:AGLE)
$0.51
$-0.01
-2.30%
Aeglea BioTherapeutics, Inc. Chart
AGLE Stock Price Today
Aeglea BioTherapeutics, Inc. (AGLE) stock declined over -2.30% intraday to trade at $0.51 a share on NASDAQ. The stock opened with a loss of -5.90% at $0.53 and touched an intraday high of $0.538, falling -1.35% against the last close of $0.517. The stock went to a low of $0.504 during the session.
Stock Snapshot
$0.517
Prev. Close
34.54 Million
Market Cap
$0.504
Day Low
$0.53
Open
66 Million
Number of Shares
$0.538
Day High
-
P/E ratio
-1.09
EPS (TTM)
1.89
Cash Flow per Share
3.39
Free Float in %
2.07
Book Value
354,554
Volume
Aeglea BioTherapeutics, Inc. Historical Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| 2022-06-30 | $0.53 | $0.538 | $0.504 | $0.505 | 354,435 |
| 2022-06-29 | $0.542 | $0.559 | $0.51 | $0.517 | 621,000 |
| 2022-06-28 | $0.584 | $0.586 | $0.54 | $0.546 | 398,000 |
| 2022-06-27 | $0.59 | $0.6 | $0.561 | $0.586 | 654,900 |
| 2022-06-24 | $0.65 | $0.651 | $0.582 | $0.582 | 4,690,900 |
| 2022-06-23 | $0.64 | $0.66 | $0.617 | $0.65 | 327,600 |
| 2022-06-22 | $0.64 | $0.66 | $0.61 | $0.646 | 279,000 |
| 2022-06-21 | $0.66 | $0.66 | $0.614 | $0.639 | 394,600 |
| 2022-06-17 | $0.66 | $0.702 | $0.65 | $0.65 | 461,000 |
| 2022-06-16 | $0.66 | $0.693 | $0.655 | $0.668 | 236,600 |
Contact Details
Company Information
Employees-
Beta1.88
Sales or Revenue18.74 Million
5Y Sales Change32.30%
Fiscal Year Ends2021-12-30
SectorHealth Care
IndustryBiotechnology
About Company
Aeglea BioTherapeutics, Inc., a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases. The company's lead product candidate is pegzilarginase, a recombinant human Arginase 1 that is in Phase III PEACE trial to evaluate the safety and efficacy for the treatment of Arginase 1 deficiency. It also develops AGLE-177, a polyethylene glycol modified, which is in Phase I/II clinical trial for the treatment of patient with homocystinuria. In addition, the company's preclinical pipeline includes AGLE-325 for the treatment of cystinuria, as well as other research programs. The company was formerly known as Aeglea BioTherapeutics Holdings, LLC and changed its name to Aeglea BioTherapeutics, Inc. in March 2015. Aeglea BioTherapeutics, Inc. was founded in 2013 and is headquartered in Austin, Texas.
Frequently Asked Questions
What is the current Aeglea BioTherapeutics, Inc. (AGLE) stock price?
Aeglea BioTherapeutics, Inc. (NASDAQ: AGLE) stock price is $0.51 as of the last check on Thursday, June 30. During the trading session, AGLE stock reached the peak price of $0.538 while $0.504 was the lowest point it dropped to.
AGLE's industry and sector of operation?
The NASDAQ listed AGLE is part of Biotechnology industry that operates in the broader Health Care sector. Aeglea BioTherapeutics, Inc. , a clinical-stage biotechnology company, designs and develops human enzyme therapeutics for the treatment of patients and families with rare metabolic diseases.
Who are the executives of AGLE?
Mr. Jonathan D. Alspaugh M.B.A.
Chief Financial Officer
Mr. Steven Weber
VP, Principal Accounting Officer & Corp. Controller
Dr. Anthony G. Quinn FRCP, M.B Ch.B., M.D., Ph.D.
Pres, CEO & Director
Dr. Leslie S. Sloan Ph.D.
Chief Operating Officer
What is the AGLE stock price today?
AGLE stock traded closed the last session at $0.505, which is $-0.01 or -2.30% lower than its previous close of $0.517. AGLE's current trading price is -0.96% lower than its 52-week high of $8.50 where as its distance from 52-week low of 0.51% is -94.06%.
How many employees does AGLE have?
Number of AGLE employees currently stands at -. AGLE operates from 805 Las Cimas Parkway, Suite 100, Austin, TX 78746, United States.
Link for AGLE official website?
Official Webiste of $AGLE is: https://www.aeglea.com
How do I contact AGLE?
AGLE could be contacted at AGLE operates from 805 Las Cimas Parkway, Suite 100, Austin, TX 78746, United States, or at phone #512 942 2935 and can also be accessed through its website.
How many shares of AGLE are traded daily?
AGLE stock volume for the day was 354,554 shares while in the previous session number of AGLE shares traded was 354,435 . The average number of AGLE shares traded daily for last 3 months was 919.4 Thousands.
How much did AGLE change today?
The percentage change in AGLE stock occurred in the recent session was -2.30% while the dollar amount for the price change in AGLE stock was $-0.01.
What price range AGLE stock been trading in?
In the recent session, the day high for AGLE stock was $0.538 while the low for AGLE stock touched on the day was $0.504.
What is the market cap of AGLE currently?
The market value of AGLE currently stands at 34.54 Million with its latest stock price at $0.51 and 66 Million of its shares outstanding.